Follow the flow chart to learn more about the procedures for submitting compounds to be screened. Upon receipt of compounds, TAACF medicinal chemists review compound information and determine the appropriate in vitro screening assays to use. Compounds may be evaluated via SRI's high-throughput screening (HTS) assays.
Blue text links are provided to downloadable documents or detailed descriptions of that step of the procedure.
Go to detailed text description.